Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT06846671
A Phase 3, Open-Label, Randomized Study of BGB-16673 Compared to Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab or Venetoclax Plus Rituximab Retreatment) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both BTK and BCL2 Inhibitors
Status
Open
Conditions
Leukemia, other
Phases
3 (Cancer Control)
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Lymphoma
Scope
National
Nct ID Number
NCT06846671
Secondary Trial ID Number
BGB-166673-302
Keywords
Treatment